SBH
DVAX

Segall Bryant & Hamill’s Dynavax Technologies DVAX Stock Holding History

Segall Bryant & Hamill’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-263,271
Closed -$2.96M – 574
2024
Q2 		$2.96M Buy
+263,271
New +$3.06M 0.05% 346

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Segall Bryant & Hamill's DVAX Position: Q3 2024 in Review

Segall Bryant & Hamill sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 263,271 shares — an estimated $2.96M sold.

Segall Bryant & Hamill first reported a position in DVAX in Q2 2024 and held it in 1 quarter. The position peaked at $2.96M in Q2 2024. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Segall Bryant & Hamill reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • Segall Bryant & Hamill sold 263,271 Dynavax Technologies shares in Q3 2024, an estimated $2.96M.
  • Segall Bryant & Hamill first reported a position in Dynavax Technologies in Q2 2024 and held it in 1 quarter.
  • Segall Bryant & Hamill's Dynavax Technologies position peaked at $2.96M in Q2 2024.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.